Patrys Limited (ASX: PAB) - Share Price
Current share price for PAB : $0.024 0.001 (4%)+
Patrys Limited (PAB) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a clinical-stage biotech creating patient and shareholder value through rapid clinical advancement of IV quetiapine for delirium and early development of Deoxymabs, an antibody platform targeting inflammatory diseases.
PAB General Information +
| ASX Code | PAB |
| Website | N/A |
| Industry/Sector | Biotechnology |
| Market Cap ($M) | 16 |
| PAB Share Price | $0.024 |
| Day High | $0.024 |
| Day Low | $0.024 |
| Last Close | $0.025 |
| PAB Share Price Movement | $0.00 ( 4% ) |
Prices as at 16:40, 30 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Patrys Limited (PAB) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Patrys Limited (PAB) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Patrys Limited (PAB) price-sensitive announcements
PAB - Appendix 4C - Quarterly - 30 September 2026
Patrys Limited’s Appendix 4C and Quarterly Activities Report for the quarter ended 30 Sept
Patrys Limited (PAB)
29 Oct 2026 | 8:11 AM
29 Oct 2026 | 8:11 AM
PAB - RLS-2202 Phase 1a Trial Advances to Cohort 2
Patrys Limited announced that its RLS-2202 Phase 1a clinical trial in healthy volunteers h
Patrys Limited (PAB)
22 Oct 2026 | 8:18 AM
22 Oct 2026 | 8:18 AM
PAB - Investor Presentation
This investor presentation from Patrys Limited (ASX:PAB) outlines the company’s lead progr
Patrys Limited (PAB)
13 Oct 2026 | 8:12 AM
13 Oct 2026 | 8:12 AM
PAB - Investor Webinar
Patrys Limited announced that its Chief Executive Officer, Dr Samantha South, will present
Patrys Limited (PAB)
6 Oct 2026 | 10:26 AM
6 Oct 2026 | 10:26 AM
Patrys Limited (PAB) Recent ASX Announcements
PAB Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | -$3.41 | -$0.80 | -40.70% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | -$2.71 | -$1.40 | -23.50% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$3.54 | -$1.80 | -50.00% | 0.00 | 0.00 | 0.00% | 0.0% |
PAB Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | ||
| CSL Limited (CSL) | $94,777M | 0.7309 | -0.4390 | 0.0602 | 12.2355 | 21.8099 | 20.5718 | 2.15% | 2.16% | 2.23% |
| Mesoblast Limited (MSB) | $3,019M | -0.4501 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 1,054.5455 | 0.00% | 0.00% | 0.00% |
| Patrys Limited (PAB) | $17M | -0.4071 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| PYC Therapeutics Limited (PYC) | $1,904M | -0.3971 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Telix Pharmaceuticals Limited (TLX) | $4,588M | -1.3893 | 0.0000 | -0.5235 | 0.0000 | 158.5882 | 332.8395 | 0.00% | 0.00% | 0.00% |
PAB Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Peter James Christie | Non-Executive Chairman, Non-Executive Director | 17 Jun 2025 |
| Mr Brian Willoughby Leedman | Non-Executive Director | 10 Nov 2025 |
| Dr Anton Uvarov | Non-Executive Director | 17 Jun 2025 |
| Ms Leanne Kite | Non-Executive Director | 28 Jan 2026 |
| Mr Dino Cercarelli | Non-Executive Director | 28 Jan 2026 |
Patrys Limited (PAB) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 3 Jul 2026 | CERCARELLI, Dino | Issued | Indirect Shares | 1,250,000 | $0.024 | $30,000.000 |
| 3 Jul 2026 | UVAROV, Anton | Issued | Direct Shares | 2,083,333 | $0.024 | $50,000.000 |
| 3 Jul 2026 | CHRISTIE, Peter | Issued | Indirect Shares | 1,250,000 | $0.024 | $30,000.000 |
See all changes in directors' interest & trades for Patrys Limited (PAB) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
PAB Management
| Name | Position |
|---|---|
| Dr. Samantha South | Chief Executive Officer |
| Kieran Witt | Joint Company Secretary |
| Johnathon Busing | Joint Company Secretary |
PAB Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Patrys Limited (PAB). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 38,712,420 (5.75%) | Leanne Kite |
PAB Calendar of Events
| Date | Event |
|---|---|
| 27 September 2027 | Report (Annual) |
| 27 September 2027 | Report (Prelim) |
| 30 August 2027 | Report (Prelim) |
| 25 February 2027 | Report (Interim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
